Regulation of Hepcidin and Iron-Overload Disease

被引:137
作者
Lee, Pauline L. [1 ]
Beutler, Ernest [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
hemochromatosis; transcription; HFE; TFR2; hemojuvelin; ferroportin; ANTIMICROBIAL PEPTIDE HEPCIDIN; JUVENILE HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR-2; HEREDITARY HEMOCHROMATOSIS; MOLECULAR-MECHANISM; MESSENGER-RNA; IDIOPATHIC HEMOCHROMATOSIS; SOLUBLE HEMOJUVELIN; HUMAN HEPATOCYTES; AFRICAN-AMERICAN;
D O I
10.1146/annurev.pathol.4.110807.092205
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hepcidin, a 25-amino-acid antimicrobial peptide, is the central regulator of iron homeostasis. Hepcidin transcription is upregulated by inflammatory cytokines, iron, and bone morphogenetic proteins and is downregulated by iron deficiency, ineffective erythropoiesis, and hypoxia. The iron transporter ferroportin is the cognate receptor of hepcidin and is destroyed as a result of interaction with the peptide. Except for inherited defects of ferroportin and hepcidin itself, all forms of iron-storage disease appear to arise from hepcidin dysregulation. Studies using multiple approaches have begun to delineate the molecular mechanisms that regulate hepcidin expression, particularly at the transcriptional level. Knowledge of the regulation of hepcidin by inflammation, iron, erythropoiesis, and hypoxia will lead to an understanding of the pathogenesis of primary hemochromatosis, secondary iron overload, and anemia of inflammatory disease.
引用
收藏
页码:489 / 515
页数:27
相关论文
共 141 条
[91]   The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation [J].
Nicolas, G ;
Chauvet, C ;
Viatte, L ;
Danan, JL ;
Bigard, X ;
Devaux, I ;
Beaumont, C ;
Kahn, A ;
Vaulont, S .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (07) :1037-1044
[92]   Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice [J].
Nicolas, G ;
Bennoun, M ;
Devaux, I ;
Beaumont, C ;
Grandchamp, B ;
Kahn, A ;
Vaulont, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8780-8785
[93]   Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice [J].
Nicolas, G ;
Andrews, NC ;
Kahn, A ;
Vaulont, S .
BLOOD, 2004, 103 (07) :2841-2843
[94]   Hepcidin, a new iron regulatory peptide [J].
Nicolas, G ;
Viatte, L ;
Bennoun, M ;
Beaumont, C ;
Kahn, A ;
Vaulont, S .
BLOOD CELLS MOLECULES AND DISEASES, 2002, 29 (03) :327-335
[95]   Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload [J].
Niederkofler, V ;
Salie, R ;
Arber, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2180-2186
[96]   A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis [J].
Njajou, OT ;
Vaessen, N ;
Joosse, M ;
Berghuis, B ;
van Dongen, JWF ;
Breuning, MH ;
Snijders, PJLM ;
Rutten, WPF ;
Sandkuijl, LA ;
Oostra, BA ;
van Duijn, CM ;
Heutink, P .
NATURE GENETICS, 2001, 28 (03) :213-214
[97]   Liver iron concentrations and urinary hepcidin in β-thalassemia [J].
Origa, Raffaella ;
Galanello, Renzo ;
Ganz, Tomas ;
Giagu, Nicolina ;
Maccioni, Liliana ;
Faa, Gavino ;
Nemeth, Elizabeta .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (05) :583-588
[98]   Suppression of hepcidin during anemia requires erythropoietic activity [J].
Pak, Mihwa ;
Lopez, Miguel A. ;
Gabayan, Victroia ;
Ganz, Tomas ;
Rivera, Seth .
BLOOD, 2006, 108 (12) :3730-3735
[99]   Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis [J].
Papanikolaou, G ;
Samuels, ME ;
Ludwig, EH ;
MacDonald, MLE ;
Franchini, PL ;
Dubé, MP ;
Andres, L ;
MacFarlane, J ;
Sakellaropoulos, N ;
Politou, M ;
Nemeth, E ;
Thompson, J ;
Risler, JK ;
Zaborowska, C ;
Babakaiff, R ;
Radomski, CC ;
Pape, TD ;
Davidas, O ;
Christakis, J ;
Brissot, P ;
Lockitch, G ;
Ganz, T ;
Hayden, MR ;
Goldberg, YP .
NATURE GENETICS, 2004, 36 (01) :77-82
[100]   Hepcidin in iron overload disorders [J].
Papanikolaou, G ;
Tzilianos, M ;
Christakis, JI ;
Bogdanos, D ;
Tsimirika, K ;
MacFarlane, J ;
Goldberg, YP ;
Sakellaropoulos, N ;
Ganz, T ;
Nemeth, E .
BLOOD, 2005, 105 (10) :4103-4105